9-valent pneumococcal polysaccharide conjugate vaccine (Yuxi Walvax biotechnology)

9价肺炎球菌多糖结合疫苗（玉溪沃森生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug Name9-valent pneumococcal polysaccharide conjugate vaccine (Yuxi Walvax biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Bacterial vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesWalvax Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesWalvax Biotechnology Co LtdYuxi Walvax Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A